The significant increase in c-FOS expression and the normalization of cortisol and serotonin levels in treated rats underscore the potential of targeted light therapy in managing conditions related to sleep deprivation and possibly other cognitive impairments. This evidence concerns the gene FOS and Cognitive impairment.